Chronic hepatitis B with human immunodeficiency virus co-infection (Q38316): Difference between revisions
From determinar.ia.br - Determine suas informações
Created a new Item |
Changed an Item |
||||||||||||||
| (7 intermediate revisions by the same user not shown) | |||||||||||||||
| description / pt-br | description / pt-br | ||||||||||||||
Doença hepática caracterizada por inflamação e fibrose hepáticas causadas por mais de 6 meses de infecção pelo vírus da hepatite B e pelo vírus da imunodeficiência humana (HIV). As manifestações clínicas incluem fadiga, endurecimento da margem hepática e complicações da cirrose (atrofia muscular, ascite, esplenomegalia/hipertensão portal) e os desfechos, incluindo carcinoma hepatocelular, são piores do que para hepatite B sem infecção por HIV. | |||||||||||||||
| description / en | description / en | ||||||||||||||
A liver disease characterised by liver inflammation and fibrosis caused by more than 6 months of infection with the hepatitis B virus and with the human immunodeficiency virus (HIV). Clinical features include fatigue, hard liver edge and complications of cirrhosis (muscle wasting, ascites, splenomegaly/portal hypertension), and outcomes, including hepatocellular carcinoma are worse than for hepatitis B without HIV infection. | |||||||||||||||
| Property / Canonical URI | |||||||||||||||
| Property / Canonical URI: https://id.who.int/icd/entity/1994012056 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / CURIE | |||||||||||||||
CID11:1E51.00 | |||||||||||||||
| Property / CURIE: CID11:1E51.00 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Canary Token | |||||||||||||||
dki-india-1E51.00 | |||||||||||||||
| Property / Canary Token: dki-india-1E51.00 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Verification Status | |||||||||||||||
Concluído | |||||||||||||||
| Property / Verification Status: Concluído / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Knowledge Architect | |||||||||||||||
| Property / Knowledge Architect: https://pauloleads.com.br/cases-publicos/ / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Collection date | |||||||||||||||
13 August 2026
| |||||||||||||||
| Property / Collection date: 13 August 2026 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Linked ICD 10 | |||||||||||||||
| Property / Linked ICD 10: B18.8 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Latest revision as of 03:17, 13 August 2026
A liver disease characterised by liver inflammation and fibrosis caused by more than 6 months of infection with the hepatitis B virus and with the human immunodeficiency virus (HIV). Clinical features include fatigue, hard liver edge and complications of cirrhosis (muscle wasting, ascites, splenomegaly/portal hypertension), and outcomes, including hepatocellular carcinoma are worse than for hepatitis B without HIV infection.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | 1E51.00 |
||
| English | Chronic hepatitis B with human immunodeficiency virus co-infection |
A liver disease characterised by liver inflammation and fibrosis caused by more than 6 months of infection with the hepatitis B virus and with the human immunodeficiency virus (HIV). Clinical features include fatigue, hard liver edge and complications of cirrhosis (muscle wasting, ascites, splenomegaly/portal hypertension), and outcomes, including hepatocellular carcinoma are worse than for hepatitis B without HIV infection. |
Statements
CID11:1E51.00
0 references
dki-india-1E51.00
0 references
Concluído
0 references
13 August 2026
0 references
